FeesSafety
Pluang+

Digital Asset raises $365M to expand Canton blockchain for regulated finance with new investors Shinhan and Standard Chartered.

Market News
22 Jul 2026, 09:42 WIB
Crypto news
View Source
Bullish
Digital Asset raises $365M to expand Canton blockchain for regulated finance with new investors Shinhan and Standard Chartered.

Digital Asset has increased its latest funding round to $365 million after securing an additional $10 million from Shinhan Financial Group and Standard Chartered’s SC Ventures. This funding boost supports the expansion of the Canton blockchain network, designed for regulated financial institutions and developers, emphasizing privacy, compliance, and operational control. The new investors enhance Digital Asset's global reach, especially in Asia, and reflect growing institutional interest in blockchain infrastructure for regulated markets. The company plans to use the capital to grow the Canton ecosystem, deepen developer and institutional engagement, and support network growth amid rising demand for privacy-enabled blockchain solutions in finance.

More News

Deadlines set for lead plaintiff in class actions against Tigo Energy, Fluence Energy, and Anavex Life Sciences

Deadlines set for lead plaintiff in class actions against Tigo Energy, Fluence Energy, and Anavex Life Sciences

Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against Tigo Energy, Fluence Energy, and Anavex Life Sciences. The lawsuits allege these companies made false or misleading stat...

Market News
Bearish
19 minutes ago
Heineken repurchases 9.5 million shares worth €679 million in latest buyback tranche

Heineken repurchases 9.5 million shares worth €679 million in latest buyback tranche

Heineken N.V. has repurchased a total of 9,510,681 shares under the second tranche of its €1.5 billion share buyback program, spending €679.2 million as of October 30, 2026. The company bought 159,700 shares on the exchange and 160,530 shares from He...

Company Fundamentals
Neutral
19 minutes ago
Alvotech to present at multiple investor conferences in November 2026.

Alvotech to present at multiple investor conferences in November 2026.

Alvotech, a global biotech company specializing in biosimilars, announced its management team will participate in several investor conferences in November 2026, including events in London, Oslo, and Stockholm. These presentations and fireside chats w...

Market News
Neutral
19 minutes ago
Alvotech to present at multiple investor conferences in November 2026

Alvotech to present at multiple investor conferences in November 2026

Alvotech, a global biotech company specializing in biosimilar medicines, announced its management team will participate in several investor conferences throughout November 2026. These include events in London, Oslo, and Stockholm, featuring presentat...

Market News
Neutral
19 minutes ago
Alvotech to present at four major investor conferences in November across Europe.

Alvotech to present at four major investor conferences in November across Europe.

Alvotech, a global biotechnology company specializing in biosimilar medicines, will participate in four international investor conferences in November held in the UK, Norway, and Sweden. These events include presentations and analyst discussions host...

Market News
Neutral
19 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App